PIONEERING HEALTHCARE FOR THE HUMAN RACE

Innovative medicine made
accessible to those in need

Latest News

06^thJuly, 2020

Assessing Value, Cost-Effectiveness & Budget Impact Analysis in Clinical Decision-Making Process To Access Healthca...

Join our 2nd webinar edition ‘Assessing Value, Cost-Effectiveness & Budget Impact Analysis in Clinical Decision-Making Process To Access Healthcare Technology’ pharmacoeconomics with Asst....

01^stJuly, 2020

In vitro study on the effectiveness of PVP-I Gargle and Mouthwash against SARS-CoV-2 virus (COVID-19)

Our Research Letter on the in vitro study on the effectiveness of PVP-I Gargle and Mouthwash against SARS-CoV-2 virus (COVID-19) is now available on the British Dental Journal (BDJ) published by...

23^rdJune, 2020

Assessing Value, Cost-Effectiveness & Budget Impact Analysis in Clinical Decision-Making Process To Access Healthca...

oin our webinar ‘Assessing Value, Cost-Effectiveness & Budget Impact Analysis in Clinical Decision-Making Process To Access Healthcare Technology’ with Asst. Prof Nermeen Ashoush, Head of...

21^stJune, 2020

Throat Emergency by Dr. Nabil Sarhan

Join our Throat Emergency Webinar by Dr Nabil Sarhan MD, Asst. prof. at Al Azhar University, and Consultant ENT at Al Hamadi Hospital in Riyadh on 22 June from 9.00 pm -10.00 pm (KSA time). Register...

15^thJune, 2020

Marc Princen appointed new Global CEO for Mundipharma

Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently associated companies as the Global Chief Executive Officer, effective June 1, 2020. In his new role,...

10^thJune, 2020

Webinar – Glaucoma

Visit iSHINE Online today to attend a webinar on the management of Glaucoma. Register and join us on http://ishineonline.info/ to learn more.

Products

Mundipharma actively works to ensure that its medicines are marketed responsibly and in accordance with the regulatory frameworks in each country it operates in. Mundipharma prides itself on being an ethical company, and continues to work closely with regulators, and within strict regulatory constraints, to address the unmet need of patients across the META region.